Dexcom (DXCM) Research & Development (2010 - 2026)
Dexcom (DXCM) posted quarterly Research & Development of $153.0 million for Q2 2026, up 3.24% year-over-year from $148.2 million in Q2 2025, and up 5.3% quarter-over-quarter from $145.3 million in Q1 2026.
Dexcom (DXCM) Research & Development (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Research & Development for 17 consecutive years, with $153.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Research & Development rose 3.24% year-over-year to $153.0 million; the TTM figure through Jun 2026 stood at $604.0 million (up 6.28% YoY), while the FY2025 annual figure was $599.1 million, up 8.45% from the prior year.
- Research & Development improved to $153.0 million in Q2 2026 per DXCM's latest filing, from $145.3 million in the prior quarter.
- Across five years, Research & Development topped out at $157.5 million in Q3 2025 and bottomed at $110.3 million in Q3 2022.
- Historically, Research & Development has averaged $135.5 million across 5 years, with a median of $136.0 million in 2023.
- On a YoY basis, Research & Development climbed as much as 24.22% in 2022 and fell as far as 22.36% in 2022.
- Dexcom's Research & Development stood at $116.3 million in 2022, then grew by 17.02% to $136.1 million in 2023, then rose by 2.5% to $139.5 million in 2024, then climbed by 6.24% to $148.2 million in 2025, then increased by 3.24% to $153.0 million in 2026.
- Business Quant data shows DXCM's Research & Development at $153.0 million in Q2 2026, $145.3 million in Q1 2026, and $148.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.43 Bn | 19.02 Bn | 1.54 Bn | 104.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 153.00 Mn |
| Mar 31, 2026 | 145.30 Mn |
| Dec 31, 2025 | 148.20 Mn |
| Sep 30, 2025 | 157.50 Mn |
| Jun 30, 2025 | 148.20 Mn |
| Mar 31, 2025 | 145.20 Mn |
| Dec 31, 2024 | 139.50 Mn |
| Sep 30, 2024 | 135.40 Mn |
| Jun 30, 2024 | 136.00 Mn |
| Mar 31, 2024 | 141.50 Mn |
| Dec 31, 2023 | 136.10 Mn |
| Sep 30, 2023 | 131.40 Mn |
| Jun 30, 2023 | 119.30 Mn |
| Mar 31, 2023 | 119.00 Mn |
| Dec 31, 2022 | 116.30 Mn |
| Sep 30, 2022 | 110.30 Mn |
| Jun 30, 2022 | 121.70 Mn |
| Mar 31, 2022 | 135.90 Mn |
| Dec 31, 2021 | 149.80 Mn |
| Sep 30, 2021 | 128.80 Mn |